Search for Clinical Trial Results
Dravet Syndrome - 26 Studies Found
Status | Study |
Not yet recruiting |
Study Name: The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy Condition:
Date: 2016-06-20 Interventions:
|
Enrolling by invitation |
Study Name: An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes Condition:
|
Recruiting |
Study Name: Genetics of Severe Early Onset Epilepsies Condition:
Date: 2013-05-09 |
Active, not recruiting |
Study Name: Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder Condition: Seizures Date: 2014-12-12 Interventions: Drug: Cannabidiol Oral Solution An oral solution containing pharmaceutical grade cannabidiol (nonplant-b |
Active, not recruiting |
Study Name: Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy Condition: Epilepsy Date: 2014-05-14 Interventions: Drug: Cannabidiol |
RECRUITING |
Study Name: A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome Condition: Dravet Syndrome Date: 2024-05-19 Interventions: The study drug, fenfluramine HCl, is an oral solution to be administered in equal doses twice daily (BID).It will be based on the current dose a |